Spinifex Pharmaceuticalsx (Australia) a clinical-stage biotechnology company focused on neuropathic pain, closed a $6.4M Series B financing. Participants include GBS Venture Partners, Brandon Capital Partners, Uniseed Management and UniQuest.

Thanx for your patience as we catch-up.